|
Immunotherapies Targeting SSX2 Peptide Displayed by MHC on Tumors
Chimeric Antigen Receptor (CAR) T cells are making headlines with their recent FDA approvals and ability to eradicate cancers. Most CAR T therapies target tumor cells via a tumor associated antigen (TAA). Unfortunately, TAAs are also expressed on non-cancerous tissues, leading to significant risk for patients. SSX2 protein expression is restricted...
Published: 1/7/2022
|
Updated: 11/16/2021
|
Inventor(s): Eric Yvon, Catherine Bollard, Stacey Van Pelt, Scott Raskin
Keywords(s):
Category(s): Technology Classifications > Therapeutics > Proteins and Peptides
|
